Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Hanjing Chen"'
Autor:
Chao Liu, Hongrong Xu, Fei Yuan, Hanjing Chen, Lei Sheng, Weili Chen, Haisong Xie, Hongmei Xu, Xuening Li
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Liraglutide is an acylated glucagon-like peptide-1 (GLP-1) analog, and its pharmacokinetic and pharmacodynamic properties as a GLP-1 receptor (GLP-1R) agonist make it an important therapeutic option for many patients with type 2 diabetes
Externí odkaz:
https://doaj.org/article/88f05422118f440692036318970a88a0
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Objective: Pharmacokinetics (PK), pharmacodynamics (PD), safety and immunogenicity studies were conducted to evaluate the bioequivalence of CMAB807, a biosimilar to denosumab (Prolia®), which is the only approved RANKL inhibitor for the treatment of
Externí odkaz:
https://doaj.org/article/a3ce38e4720a48a08ddfb85b5bc8707a
Publikováno v:
Acta Crystallographica Section E, Vol 66, Iss 10, Pp o2660-o2660 (2010)
In the title compound, C20H24FNO3S, the piperidine ring adopts a chair conformation. The dihedral angle between the aromatic rings is 47.01 (17)°.
Externí odkaz:
https://doaj.org/article/3b36e38b4557438586e787dc81309f4a
Autor:
Chao Liu, Hongrong Xu, Fei Yuan, Hanjing Chen, Lei Sheng, Weili Chen, Haisong Xie, Hongmei Xu, Xuening Li
Publikováno v:
Frontiers in Pharmacology; 2024, p01-10, 10p
Autor:
Fei, Yuan, Jing, Li, Xuening, Li, Hui, Li, Weili, Chen, Mengjie, Yang, Hanjing, Chen, Lei, Sheng, Chao, Liu, Yujia, Wu, Hongrong, Xu
Publikováno v:
Clinical Pharmacology in Drug Development. 12:168-174
Chiglitazar, a pan agonist of non-thiazolidinedione peroxisome proliferator-activated receptor, has the potential to regulate blood sugar, improve lipid metabolism, and reduce cardiovascular complications. This study aimed to examine the effect of cy
Publikováno v:
Biochemical and Biophysical Research Communications. 606:55-60
Proprotein convertase subtilisin/kexin type 9 (PCSK9), a negative regulator of LDLR, has emerged as an important target for the treatment of hypercholesterolemic cardiovascular disease, and monoclonal antibodies alirocumab and evolocumab against it h
Autor:
Hanjing Chen
Publikováno v:
Proceedings of the 2nd International Conference on Culture, Design and Social Development (CDSD 2022) ISBN: 9782384760176
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::722880d006ae225c48069c26331e6417
https://doi.org/10.2991/978-2-38476-018-3_16
https://doi.org/10.2991/978-2-38476-018-3_16
Publikováno v:
Leadership & Organization Development Journal. 42:1153-1167
PurposeThe purpose of this paper is to investigate the double-edged effects of supervisor bottom-line mentality (BLM) on subordinates' work-related behaviors (work performance and knowledge hiding) and the moderating role of subordinate gender.Design
Autor:
Fei Yuan, Hui Li, Mengjie Yang, Weili Chen, Hanjing Chen, Hongrong Xu, Jing Li, Lei Sheng, Chao Liu, Ye Li, Huan Li, Xuening Li
Publikováno v:
Clinical pharmacology in drug developmentReferences.
Icosapent ethyl (IPE) is a high-purity prescription form of eicosapentaenoic acid (EPA) ethyl ester that has been approved to lower triglyceride levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia. Before this study, there were n
Autor:
Lei Sheng, Mengjie Yang, Chunjiu Zhong, Wei-Li Chen, Chao Liu, Xue-Ning Li, Ping-ping Lin, Wei Cao, Hanjing Chen, Fei Yuan, Hui Li, Hong-Rong Xu
Publikováno v:
Drug Design, Development and Therapy
Lei Sheng,1,* Wei Cao,2,* Pingping Lin,3 Weili Chen,1 Hongrong Xu,1 Chunjiu Zhong,4 Fei Yuan,1 Hanjing Chen,1 Hui Li,1 Chao Liu,1 Mengjie Yang,1 Xuening Li1 1Department of Clinical Pharmacology, Zhongshan Hospital, Fudan University, Shanghai, 200032,